Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    July 2018
  1. LIGHT M, Orr JE, Malhotra A, Owens RL, et al
    Continuous positive airway pressure device detects atrial fibrillation induced central sleep apnoea.
    Lancet. 2018;392:160.
    PubMed     Text format    


    August 2017
  2. VINEREANU D, Lopes RD, Bahit MC, Xavier D, et al
    A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32165.
    PubMed     Text format     Abstract available


    July 2017
  3. DESIMONE CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, et al
    Cerebral amyloid angiopathy and implications for atrial fibrillation management.
    Lancet. 2017;390:9-11.
    PubMed     Text format    


    April 2017
  4. KIRCHHOF P
    The future of atrial fibrillation management: integrated care and stratified therapy.
    Lancet. 2017 Apr 28. pii: S0140-6736(17)31072.
    PubMed     Text format     Abstract available


    March 2017
  5. HEALEY JS, Oldgren J
    Risk of mortality and stroke after atrial fibrillation - Authors' reply.
    Lancet. 2017;389:907.
    PubMed     Text format    


  6. HUO Z
    Risk of mortality and stroke after atrial fibrillation.
    Lancet. 2017;389:907.
    PubMed     Text format    


  7. MIHAS C, Mariolis A, Letsas KP, Kantzanou M, et al
    Risk of mortality and stroke after atrial fibrillation.
    Lancet. 2017;389:906.
    PubMed     Text format    


    October 2016
  8. HIJAZI Z, Oldgren J, Lindback J, Siegbahn A, et al
    The ABC risk score for patients with atrial fibrillation - Authors' reply.
    Lancet. 2016;388:1980-1981.
    PubMed     Text format    


  9. CHARIDIMOU A
    The ABC risk score for patients with atrial fibrillation.
    Lancet. 2016;388:1979.
    PubMed     Text format    


  10. PROVIDENCIA R, Lambiase PD
    The ABC risk score for patients with atrial fibrillation.
    Lancet. 2016;388:1979-1980.
    PubMed     Text format    


    August 2016
  11. BRIASOULIS A, Afonso L
    Do NOACs ENSURE safe cardioversion in atrial fibrillation?
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31410.
    PubMed     Text format    


  12. GOETTE A, Merino JL, Ezekowitz MD, Zamoryakhin D, et al
    Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31474.
    PubMed     Text format     Abstract available


  13. PICCINI JP, Fauchier L
    Rhythm control in atrial fibrillation.
    Lancet. 2016;388:829-840.
    PubMed     Text format     Abstract available


  14. VAN GELDER IC, Rienstra M, Crijns HJ, Olshansky B, et al
    Rate control in atrial fibrillation.
    Lancet. 2016;388:818-828.
    PubMed     Text format     Abstract available


  15. FREEDMAN B, Potpara TS, Lip GY
    Stroke prevention in atrial fibrillation.
    Lancet. 2016;388:806-817.
    PubMed     Text format     Abstract available


  16. THE LANCET
    Atrial fibrillation and stroke: unrecognised and undertreated.
    Lancet. 2016;388:731.
    PubMed     Text format    


  17. LARSEN TB, Nielsen PB
    Stroke and mortality after atrial fibrillation-a global struggle.
    Lancet. 2016 Aug 8. pii: S0140-6736(16)31274.
    PubMed     Text format    


  18. HEALEY JS, Oldgren J, Ezekowitz M, Zhu J, et al
    Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study.
    Lancet. 2016 Aug 8. pii: S0140-6736(16)30968.
    PubMed     Text format     Abstract available


    July 2016
  19. O'DONNELL MJ, Chin SL, Rangarajan S, Xavier D, et al
    Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30506.
    PubMed     Text format     Abstract available


    April 2016
  20. CAMPANILE A, Tavazzi G, Alam MH, Paul R, et al
    An unexpected finding in an asymptomatic patient with atrial fibrillation: cardiac angiosarcoma.
    Lancet. 2016 Apr 7. pii: S0140-6736(16)00086.
    PubMed     Text format    


  21. HIJAZI Z, Oldgren J, Lindback J, Alexander JH, et al
    The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
    Lancet. 2016 Apr 1. pii: S0140-6736(16)00741.
    PubMed     Text format     Abstract available


  22. KIRCHHOF P, Fabritz L
    Can biomarkers balance stroke and bleeding risk?
    Lancet. 2016 Apr 1. pii: S0140-6736(16)30121.
    PubMed     Text format    


    February 2016
  23. BLACHER J, Levy BI, Mourad JJ, Safar ME, et al
    From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century.
    Lancet. 2016 Feb 5. pii: S0140-6736(16)00002.
    PubMed     Text format    


    October 2015
  24. THAN M, Peacock WF
    Supraventricular tachycardia: back to basics.
    Lancet. 2015;386:1712.
    PubMed     Text format    


  25. APPELBOAM A, Reuben A, Mann C, Gagg J, et al
    Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial.
    Lancet. 2015;386:1747-53.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: